SCHEMBL1075532

SCHEMBL1075532

Nc1cc(C2CCC(C(=O)O)CC2)nc2ccnn12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.55
CCNA1 P78396 2/20 0.55
CHEK1 O14757 1/20 0.55
CCNA2 P20248 1/20 0.55
SRC P12931 1/20 0.42
PDE10A Q9Y233 1/20 0.41
PDE4D Q08499 6/20 0.39
PDE4A P27815 5/20 0.39
PDE4B Q07343 5/20 0.39
PDE4C Q08493 5/20 0.39
NEK2 P51955 3/20 0.37
CCNT1 O60563 1/20 0.37
CDK9 P50750 1/20 0.37
DGAT1 O75907 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7846641 0.87 CHEK1 (0.68) CDK2CCNA1CHEK1CCNA2SRC
SCHEMBL1023295 0.85 PDE4D (0.42) CDK2CCNA1CHEK1CCNA2PDE10A
SCHEMBL585004 0.85 CDK2 (0.51) CDK2CCNA1CHEK1CCNA2SRC
SCHEMBL10236643 0.85 CDK2 (0.51) CDK2CCNA1CHEK1CCNA2SRC
SCHEMBL16086901 0.84 PDE10A (0.48) CDK2CCNA1CHEK1CCNA2PDE10A
SCHEMBL593655 0.83 CDK2 (0.54) CDK2CCNA1CHEK1CCNA2SRC
SCHEMBL6890507 0.82 CDK2 (0.48) CDK2CCNA1CHEK1CCNA2SRC
SCHEMBL10277723 0.82 CDK2 (0.48) CDK2CCNA1CHEK1CCNA2SRC
SCHEMBL10236616 0.81 CDK2 (0.49) CDK2CCNA1CHEK1CCNA2SRC
SCHEMBL584858 0.80 CHEK1 (0.59) CDK2CCNA1CHEK1CCNA2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448942-A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS Schering Corporation (US) 2012-05-09 EP disclosed
WO-2012027240-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed
WO-2011002887-A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS SCHERING CORPORATION (US) 2011-01-06 WO disclosed